Investigation Report on China Tropisetron Market, 2010-2019

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experienc…
Reference: 1506199
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
6/4/2015
Pages
30
Version:
2010
Charts:
30
Language
  • English
  • Chinese
Format
License

Description
Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may even feel unwilling or give up further chemotherapy, which will make chemotherapy difficult to continue. 5-HT3 receptor antagonist, an antiemetic, acts by competitively preventing 5-HT from combining with 5-HT3 receptor. Ever since GSK developed the first generation of selective 5-HT3 receptor antagonist ondansetron under the trade name of Zofran, a bunch of derivatives have come out, including tropisetron made by Novartis under the trade name of Navoban.
Tropisetron, developed by Novartis, entered the market in the Netherlands in 1992 and then the Chinese market in the late 1990s. Tropisetron got administrative protection authorized by the Chinese government in Mar. 1994 after its original developer Sandoz submitted application. But it is now a generic drug for its patent expired on Sep. 22, 2001. Tropisetron develops fast into the absolute leader antiemetics after entering China with annual sales rising from CNY 41 million in 2005 to CNY 600 million in 2014 and CAGR reaching up to 34.7% during the period of 2005-2014. Currently, the tropisetron market in China is basically occupied by generic drugs which come from the following companies: Southwest Pharamceutical Co., Ltd, Wellso Pharmaceutical Co., Ltd, ReYoung Pharmaceutical Co., Ltd, Shandong Luoxin Pharmacy Stock Co., Ltd and Qilu Pharmaceutical Co., Ltd
Tropisetron has big profit margins and is easy to be applied to clinics. Since there are hundreds of thousands of cancer patients undergoing chemoradiotherapy, tropisetron enjoys a promising market in China.

Readers can get at least the following information through this report:
-market share of manufacturers of tropisetron in Chinese market
-price of tropisetron in Chinese market
-major manufacturers of tropisetron in China
-share of different dosage forms of tropisetron in Chinese market
-market outlook of tropisetron in China

The author suggests the following groups of people purchase this report:
-pharmaceutical enterprises
-investors/ research institutions interested in Chinese medicine market
-any interest in Chinese medicine market, please contact CRI for customized survey service
Table of Contents

1 Related Concepts of Tropisetron
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Tropisetron in China
2.1 Patent and Approval Status of Tropisetron in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Tropisetron in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Tropisetron in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Tropisetron in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Tropisetron in Chinese Hospitals in 2014
6.1 Wellso Pharmaceutical Co., Ltd (Trade Name: Shu Ou Ting)
6.2 Beijing SL Pharmaceutical Co., Ltd
6.3 Sichuan Taiji Pharmaceutical Co., Ltd., Taiji Group
6.4 Shandong Linzi Pharmaceutical Co., Ltd
6.5 ReYoung Pharmaceutical Co., Ltd
6.6 Shandong Luoxin Pharmacy Stock Co., Ltd
6.7 Qilu Pharmaceutical Co., Ltd
6.8 Jiangsu Hengrui Medicine Co., Ltd
6.9 Lionco Pharmaceutical Group
6.10 Southwest Pharamceutical Co., Ltd
6.11 Harbin Medisan Pharmaceutical Co., Ltd

7 Major Manufacturers of Tropisetron in Chinese Market, 2010-2014
7.1 ReYoung Pharmaceutical Co., Ltd
7.2 Shandong Luoxin Pharmacy Stock Co., Ltd
7.3 Qilu Pharmaceutical Co., Ltd
7.4 Southwest Pharamceutical Co., Ltd
7.5 Wellso Pharmaceutical Co., Ltd

8 Market Outlook of Tropisetron in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Selected Charts
Chart Approval Information of Tropisetron in China
Chart Sales Status of Tropisetron in China, 2010-2014
Chart Sales Value of Tropisetron in China, 2010-2014
Chart Sales Value of Tropisetron in Some Regions in China, 2010-2014
Chart Sales Volume of Tropisetron in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Tropisetron for Sales Volume in China, 2010-2014
Chart Sales Value and Market Share of Tropisetron Made by Southwest Pharamceutical in China, 2010-2014
Chart Sales Value and Market Share of Tropisetron Made by Qilu Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Tropisetron Made by Wellso in China, 2010-2014
Chart Sales Value and Market Share of Tropisetron Injection in China, 2010-2014
Chart Price of Tropisetron Made by Wellso Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tropisetron Made by Beijing SL Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tropisetron Made by Shandong Luoxin Pharmacy Stock Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tropisetron Made by in Some Chinese Cities in 2014
Chart Price of Tropisetron Made by Jiangsu Hengrui Medicine Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tropisetron Made by Southwest Pharamceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tropisetron Made by Harbin Medisan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Scroll